Патоморфологічні зміни аерогематичного бар’єра при гострому респіраторному дистрес-синдромі в експерименті

N. Yu. Novikov; L. V. Tyshkevich; K. M. Dzhansyz

doi:10.14739/2310-1237.2012.1.15856

Authors

N. Yu. Novikov
L. V. Tyshkevich
K. M. Dzhansyz

DOI:

https://doi.org/10.14739/2310-1237.2012.1.15856

Keywords:

surfactant of the lungs, acute respiratory distress-syndrome, the treatment, the morphology

Abstract

Changes in the lungs of nonlinear white rats with a modeled acute respiratory distress syndrome without any therapy are characterized by progression of destructive necrotic processes with increasing of exudation and infl ammatory infi ltration during all 6 days of experiment. Infl ammatory reactions are replaced by fi brosis when simultaneous antibacterial and substitutive surfactant therapy is applied. Administration of only antibacterial therapy leads to prolongation of destructive infl ammatory process and deceleration of fi brosis appearance by 6 day of experiment.

References

Глумчер Ф.С. Острый респираторный дистресс-синдром: определение, патогенез, терапия / Ф.С. Глумчер // Мистецтво лікування. – 2004. – №9. – С. 30–35.

Межирова Н.М. Патофизиологические и диагностические аспекты синдрома системного воспалительного ответа / Н.М. Межирова, В.В. Данилова, С.С. Овчаренко // Медицина неотложных состояний. – 2011. – №1–2. – C. 32–33.

Плотников Г.П. Лечение вирусно-бактериальных пневмоний у беременных и родильниц в период сезонного гриппа 2009 г. (многоцентровое исследование)/ Г.П. Плотников, Д.Л. Шукевич, Ю.А. Чурляев [и др.] // Общая реаниматология. – 2010. – Т. 6, №5. – С. 5–10.

Stapleton R D. Causes and Timing of Death in Patients With ARDS/ R.D. Stapleton, B.M. Wang, L.D. Hudson [et al.]// Chest. –2005. – №128. – P. 525–532

Рекалова Е.М. Поражения легких в период пандемии свиного гриппа А(H1N1) 2009–2010 гг. / Е.М. Рекалова // Клиническая иммунология. Аллергология. Инфектология. – 2010. – №3. – С. 42–48.

Mary B.B. The Pathologist's Approach to Acute Lung Injury/ B.B. Mary // Archives of Pathology & Laboratory Medicine. – 2010. – Vol. 134, №5. – P. 719–727.

Sabater J. Effects of an omega-3 fatty acid-enriched lipid emulsion on eicosanoid synthesis in acute respiratory distress syndrome (ARDS): A prospective, randomized, double-blind, parallel group study/ J. Sabater, J. R. Masclans, J. Sacanell [at al.] // Nutrition & Metabolism (London). – 2011. – V. 8. – P. 8–22.

Orme J.Jr. Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome/ J.Jr. Orme, J.S. Romney, R.O. Hopkins [et al.]//Am. J. Respir. Crit. Care. Med. – 2003. – №167. – P. 690–694.

Barrios RJ. Hypersensitivity pneumonitis: histopathology/ R.J. Barrios//Arch. Pathol. Lab. Med. – 2008. – №132 (2). – P. 199–203.

Shieh WJ. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States/ W.J. Shieh, D.M. Blau, A.M. Denison [et al.] // Am. J. Pathol. – 2010. – №177 (1). – P. 13–14.

Stevens T. Lung Vascular Cell Heterogeneity. Endothelium, Smooth Muscle, and Fibroblasts / Stevens T., Phan S., Frid M.G. et al. // The Proceedings of the American Thoracic Society. – 2008. – V. 5. – P. 783–791.

Kox M. The selective α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced inflammation and lung injury / M. Kox, J.C. Pompe, M. Vaneker [et al.] // Critical Care. – 2009. – №13. – P. 55.

Hegeman M.A. Systemic administration of E-selectin-directed dexamethasone liposomes attenuates pulmonary inflammation in a mouse model of ventilator-induced lung injury/ M.A. Hegeman, P.M. Cobelens, M.P. Hennus., [et al.] // Critical Care. – 2009. – №13. – P. 327.